Zurich / Glattbrugg | December 7, 2017
Cytosurge, a Swiss company that develops and distributes scientific measuring instruments and robotic systems based on its patented FluidFM® technology, and JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, announce their partnership. Thanks to this partnership, JPK’s NanoWizard® AFM users will now be able to add Cytosurge’s unique FluidFM technology that opens up a new world of applications. In single cell experiments it gives the user, for example, the broadest range of force control available.
JPK users of NanoWizard®, CellHesion® and ForceRobot® systems may now add FluidFM technology for applications requiring the precise control of liquids at the femtoliter scale. Being able to isolate, manipulate and image single & multiple cells in their natural environments is vital to researchers in many fields, notably those involved in drug discovery, early stage diagnosis and cellular force interactions making the addition of FluidFM to the world of AFM imaging and force spectroscopy an ideal pairing.
CEO of Cytosurge, Dr Pascal Behr is looking forward to collaborate with JPK: “Our vision at Cytosurge is to provide a new generation of tools to stimulate novel applications at the forefront of nanotechnology, life sciences and single cell biology. Our patented FluidFM technology and our experience in the market gives us a state of the art leadership position. Seeing how JPK have successfully sold in the bio and pharma markets with their SPM products, JPK is an excellent partner for us to make our technology available to more AFM users. We are looking forward to a successful partnership with JPK resulting in a win-win-win situation; for our customers, JPK Instruments, and us.”
For JPK’s Head of Sales, Dr Hauke Kahl, the new partnership making FluidFM available to JPK AFM users yields to three key user benefits: “First, JPK users can already study materials over a broad range of forces, from piconewton levels with optical tweezers (NanoTracker™) through conventional AFM imaging & force spectroscopy to the low nanonewton range. Adding FluidFM enables measurements up to 50nN and even higher, giving us a broader range of force control than with any other instrument scanning probe microscopy (SPM) combination. Furthermore, with the special FluidFM probes, a user may deliver liquid, e.g. a new drug formulation, directly into an individual cell or extracellularly over a larger volume area. The AFM is then used to track any changes in topography or in interactive forces. Lastly, providing a significant benefit over the use of glass pipettes, FluidFM® probes can carry out effective transfection of DNA. This could become very important to those studying sensitive iPS stem cells.”
The Partnership with JPK is the second of a series between Cytosurge and leading AFM manufacturers, designed to make FluidFM available to as many AFM users as possible. Dr Michael Gabi, CTO of Cytosurge, describes the FluidFM AFM Partnership Program: “We work closely together with established AFM manufacturers to deliver high quality solutions and maximize customer value. Our unique program will allow new and existing AFM owners to leverage their AFM investments to their full potential."
FluidFM – GO BEYOND.
About JPK Instruments AG
JPK Instruments AG is a world-leading manufacturer of nanoanalytic instruments - particularly atomic force microscope (AFM) systems and optical tweezers - for a broad range of applications reaching from soft matter physics to nano-optics, from surface chemistry to cell and molecular biology. JPK’s focus in life sciences and soft matter research has driven its success in uniting the worlds of nanotechnology tools and life science applications by offering cutting-edge technology and unique applications expertise. Headquartered in Berlin, Germany, JPK maintains offices around the world and a global network of distributors and support centers.
About Cytosurge AG
Cytosurge AG was founded as an ETH Zurich spin-off in 2009 and successfully develops and distributes scientific measuring instruments and robotic systems based on its patented FluidFM technology. Cytosurge is focusing its activities into three distinct customer-focused business units: AFM SOLUTIONS, CELL & BIOSCIENCE and 3DPRINTING, each perfectly adapted to its specific target market. Whether via the revolutionary FluidFM nanosyringe, the fully integrated FluidFM BOT system, or the award-winning μ3Dprinter, Cytosurge provides leading-edge tools and processes to those who want to go beyond current technological boundaries.
FluidFM – GO BEYOND.
Tel. +41 43 544 87 20